top of page
Daren A. Luma Firm Logo.png
The New York Stock Exchange facade on Broad Street

FINRA Orders Spartan Capital to Pay $3.18 Million Over Pre-Initial Public Offering ("Pre-IPO") Funds: What Atlas Funds and StraightPath Investors Can Do

dluma9
4 days ago
10 min read

On November 17, 2026, the Financial Industry Regulatory Authority ("FINRA") announced that it had ordered Spartan Capital Securities, LLC, a New York City firm, to pay $2,176,398.20 in restitution to customers and a $1,000,000 fine, a total of about $3.18 million. The October 22, 2026 order resolves a disciplinary complaint about recommendations of affiliated Atlas Funds, which invested in pre-initial public offering ("pre-IPO") interests through funds managed by StraightPath Venture Partners, LLC. Without admitting or denying the allegations, Spartan, its former chief executive officer, John Lowry, and its former acting chief compliance officer, Kim Monchik, consented to the settlement. FINRA found that the firm failed to conduct reasonable due diligence, failed to fully disclose conflicts of interest, and used offering documents that misrepresented material facts, in violation of Regulation Best Interest ("Reg BI") and the anti-fraud provisions of the Securities Act of 1933. If you invested in Atlas Funds, a StraightPath fund, or another pre-IPO private placement, and you lost $100,000 or more, call (914) 304-4051 for a free consultation.

What happened

FINRA's order accepting the Offer of Settlement is dated October 22, 2026 (Disciplinary Proceeding No. 2021069218305). The complaint was filed on November 24, 2025. The respondents consented to the entry of findings, without admitting or denying the allegations. According to the order and FINRA's November 17 news release:

  • Spartan Capital Securities (CRD No. 146251) has been a FINRA member since 2008. It is headquartered in New York, New York, employs approximately 85 registered persons in three branch offices in the New York City metropolitan area, and services approximately 5,000 retail customer accounts.

  • Between March 2021 and October 2021, Spartan made 344 recommendations, totaling approximately $24 million, to 186 customers, most of them retail, through 16 private placement offerings.

  • The offerings were issued by Atlas Fund III, LLC, Atlas Fund IV, LLC, and Atlas Fund V, LLC, managed by Atlas Fund Management LLC. Lowry was the sole owner and control person of the Atlas Funds and of the manager. Spartan was the sole placement agent.

  • Each offering charged a 10 percent placement fee payable to Spartan. Atlas Fund Management also charged a two percent management fee and a 20 percent back-end carried interest fee. The recommendations generated approximately $2.4 million in placement fees for Spartan and approximately $480,000 in management fees for the manager.

FINRA found that Spartan willfully violated Reg BI's Care Obligation, Exchange Act Rule 15l-1(a)(1), because it lacked a reasonable basis to believe the recommendations were in the best interest of retail customers. FINRA also found violations of the anti-fraud provisions of the Securities Act, of Reg BI's Disclosure Obligation, and of FINRA's supervision rules. The settlement censures Spartan, fines it $1,000,000, and orders restitution of $2,176,398.20 to the "Eligible Customers" listed on Attachment A. Lowry, an owner and the former CEO of Spartan and the sole owner of the Atlas Funds, was suspended for two years in all capacities and fined $25,000. Monchik, the firm's former acting chief compliance officer and former chief administrative officer, was barred from associating with any FINRA member firm in all capacities.

How the Atlas Funds and the StraightPath structure worked

Pre-IPO private placements can offer exposure to private companies that are expected to go public. Investors usually do not own those companies' shares directly. They buy interests in a fund that is supposed to hold the shares, which can make it harder to see what you own, what you paid, and who is taking a fee or a markup. Learn more about private placements and alternative investments.

According to the order, investors in each offering bought a membership interest in one of the three Atlas Funds in order to invest indirectly in a single pre-IPO company that Lowry selected. The Atlas Funds did not buy those shares directly. They purchased membership interests in SP Venture Fund 8, LLC, which the order calls StraightPath Fund, a private fund managed by StraightPath Venture Partners, LLC, which in turn purported to purchase shares in the named company. Spartan and the Atlas entities shared the same office and staff. Lowry chose the companies, negotiated the StraightPath Fund purchases, and set the price investors would pay, including the markups.

Those markups are at the center of the case. In an example the order labels "Company One," Lowry negotiated the purchase of StraightPath Fund interests at a price per share equivalent of $1450, then priced the offering to investors at $1635, or $185 per share higher. Investors therefore paid 12.75 percent more than the Atlas Funds paid. Across the program, Lowry caused the Atlas Funds to apply markups on 15 of the 16 offerings. The markups ranged from 12.75 percent to 36.4 percent and totaled approximately $3.25 million, which, the order says, directly benefited Lowry, who owned and controlled those entities. Those charges were in addition to the placement and management fees.

FINRA also found that the private placement memoranda ("PPMs") and offering supplements were materially misleading about who charged those markups and who kept them. The documents indicated that a third-party affiliate, Iapetus, LLC, would sell interests to the Atlas Funds at a markup, and that the Atlas Funds would not share in that profit. According to the order, there was no third-party intermediary. The Atlas Funds bought the interests directly from StraightPath Fund, then charged investors the markup and retained the profit. FINRA found that this concealed Lowry's additional compensation and created the false impression that a third party had earned the markup by sourcing the investments. The order says Lowry's ownership and control of Iapetus was not disclosed in the supplement.

The due diligence and supervision failures

Before a firm recommends a private placement, it has to reasonably investigate the offering. Reg BI's Care Obligation also requires a firm and its financial advisors to have a reasonable basis to believe that a recommendation is in the retail customer's best interest, and not to place their own interest ahead of the customer's. FINRA found that Spartan, through Monchik, did not reasonably investigate StraightPath, its principals, or the funds it managed; did not confirm that StraightPath Fund possessed, or had access to, the underlying pre-IPO shares; and did not consider the pricing, including markups, or whether StraightPath itself applied additional markups.

Monchik first asked StraightPath Fund for proof that it owned or had access to the shares on March 31, 2021, after Spartan had already sold three of the offerings. She received no response, followed up on May 28, and asked again on June 9. The sales continued anyway. By June 15, 2021, Spartan had sold eight offerings, and the Atlas Funds had sent StraightPath Fund approximately $11.8 million for interests that purported to hold shares of six pre-IPO companies, all without confirmation that StraightPath Fund actually owned those shares. StraightPath Fund responded that day with documents for four companies in five offerings. It never produced documents for the other three, and the documents it did send, FINRA found, did not establish possession of the shares. After June 15, Spartan financial advisors recommended eight new offerings, and the Atlas Funds sent more money, still without that proof.

FINRA also found that Monchik's investigation of StraightPath itself was not reasonable. The order says it consisted of very limited internet research and background checks, including a Lexis search of a Georgia entity called "StraightPath Ventures LLC" that had no connection to StraightPath's manager. She did not review StraightPath's financial statements or identify its owner. Although she had no prior experience with pre-IPO offerings, Lowry made her president of the Atlas entities, and beginning in July 2020 she spent approximately 40 percent of her time on that work. Lowry owned and controlled the recommending firm, the funds, and the manager that collected fees and markups. Monchik was also responsible for compliance at Spartan, including as interim chief compliance officer from July 2020 until December 2021, while performing due diligence for both sides. FINRA found that the offering documents did not fully and fairly disclose those conflicts, and that Spartan and Monchik failed to establish written policies reasonably designed to achieve compliance with Reg BI or to supervise the recommendations.

The FINRA order is not a criminal case against Spartan or its former executives. It notes that StraightPath's manager is in a receivership as a result of Securities and Exchange Commission ("SEC") litigation, and that the Department of Justice has brought criminal charges against its principals. FINRA's news release adds that, in a separate criminal case unrelated to Spartan and its former executives, three former StraightPath principals were sentenced in May to eight to 11 years in federal prison for defrauding investors in StraightPath funds, including through undisclosed markups and by selling interests in funds that did not actually possess or have access to the underlying shares.

What the restitution order does, and does not, do

A FINRA fine and a restitution order are not the same thing as an investor's own recovery. The order requires Spartan to pay $2,176,398.20 to the Eligible Customers listed on Attachment A, and to provide proof of payment within 120 days after notice that the offer was accepted, or a plan for any unpaid amounts. Attachment A is not included in the 34-page order FINRA posted with the news release, so the public document does not identify those customers or show how each person's figure was calculated. The restitution is much smaller than the approximately $24 million in principal that customers invested, and smaller than the approximately $3.25 million in markups described in the findings. The order does not say that the restitution covers every loss an investor may have suffered. It does say, expressly, that the restitution order and the other monetary sanctions do not preclude customers from pursuing their own actions to obtain restitution or other remedies.

This is also not the only recent public matter involving Spartan Capital. Earlier this month I wrote about a separate FINRA action involving a Spartan Capital financial advisor in Hollis, New York, who was suspended for excessive trading in a retiree's account. That case is not part of this settlement.

What investors should check

You do not have to wait for a restitution letter to look at what you were sold. Pull your subscription documents, the PPM and any supplements, account statements, and notes of what you were told, and look for:

  1. An investment in Atlas Fund III, Atlas Fund IV, Atlas Fund V, or another fund that was supposed to hold pre-IPO shares through StraightPath or an "SP Venture" fund

  2. A purchase price, fee, or markup that does not match what you were told, or that you cannot reconcile to an underlying share price

  3. Language about a third-party affiliate, an intermediary, or a statement that the fund would not share in markup profits

  4. Placement fees, management fees, or a carried-interest fee stacked on top of the price you paid

  5. Little or no documentation showing that the fund actually possessed, or had a right to, the underlying pre-IPO shares

  6. An illiquid position you cannot sell, a long delay after a company has gone public, or a distribution much smaller than you expected

  7. A large share of your net worth or retirement savings in one pre-IPO offering or in a group of similar private placements

You can request a complete account history and a copy of the offering documents from the firm. Compare what you signed with what you were told. Check your financial advisor and the firm on FINRA's free BrokerCheck. Spartan Capital Securities, LLC is firm CRD number 146251. Lowry is CRD number 4336146. Monchik is CRD number 2528972.

How FINRA arbitration works, and the deadlines

Most brokerage account agreements require disputes to go to FINRA arbitration rather than court. A claim is usually decided by a panel of one or three arbitrators, and the process is generally faster and less formal than litigation.

Under FINRA Rule 12206, a claim generally is not eligible for FINRA arbitration if more than six years have passed since the events that gave rise to it. The recommendations described in this order ran from March 2021 through October 2021. As of today, those events generally still fall within that six-year window, but the earliest sales, from the spring of 2021, are only a few months from the six-year mark, and some could fall outside it depending on which events are treated as giving rise to the claim. Some investors may also have received later advice about the investment, including advice to hold. Arbitration panels have split on whether that kind of ongoing advice can affect the analysis, and the answer depends on the facts. Shorter state-law statutes of limitation can also apply, and some are as short as two or three years. Courts and arbitrators may look at when an investor discovered, or reasonably should have discovered, the problem. It is important to act promptly. You can read more about the process in Can I Sue My Financial Advisor in New York?.

How I can help

I represent investors in FINRA arbitration against brokerage firms. I served as in-house counsel at one of the largest brokerage firms and worked at one of the largest defense law firms in the world. I have represented over 400 clients and recovered over $130mm for investors. Prior results do not guarantee a similar outcome. I focus on investors with losses of $100,000 or more and represent clients nationwide, including in New York City and New York State. The consultation is free, and my firm is paid only if you recover. Contact me or call (914) 304-4051.

Frequently asked questions

Did Spartan or the executives admit the findings?

No. They consented to the settlement without admitting or denying the allegations of the disciplinary complaint.

If I receive restitution under this order, can I still bring a claim?

Possibly. The order says the restitution and the other monetary sanctions do not stop customers from pursuing their own actions. The $2,176,398.20 figure is the regulatory restitution for the Eligible Customers listed on Attachment A, which is not in the public order. It is not a ruling on every loss a particular investor may have.

I invested in a StraightPath fund, but not through Spartan or the Atlas Funds. Does this order apply to me?

This order is about Spartan's recommendations of the Atlas Funds. It is not a recovery program for every StraightPath investor. The SEC case, the receivership, and the criminal sentences described in FINRA's news release are a separate matter. Whether you have a claim depends on who sold you the investment, what you were told, and your records.

I signed the paperwork, or I was told I was an accredited investor. Can I still have a claim?

Possibly. Reg BI looks at whether the recommendation was in your best interest at the time it was made, not only at whether you signed a form or met an accreditation standard. Whether you have a claim depends on your records and circumstances.

How do I look up this firm or these individuals?

Search FINRA's free BrokerCheck by name or CRD number. Spartan Capital Securities, LLC is firm CRD number 146251. John Lowry is CRD number 4336146. Kim Monchik is CRD number 2528972.

Attorney Advertising. This post is for general information only and is not legal advice. Reading it does not create an attorney-client relationship. Prior results do not guarantee a similar outcome. FINRA's findings were made in a settlement without admission or denial. Daren A. Luma, PLLC, 75 South Broadway, Suite 400, White Plains, NY 10601, (914) 304-4051.

 
 
 

Comments


bottom of page